tradingkey.logo
搜尋

QuidelOrtho Corp

QDEL
添加自選
18.250USD
+0.070+0.39%
收盤 07/02, 13:00美東報價延遲15分鐘
1.24B總市值
虧損本益比TTM

QuidelOrtho Corp

18.250
+0.070+0.39%
查看詳細走勢圖
TradingKey 图表
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

+0.39%

5天

+32.34%

1月

+19.28%

6月

-36.59%

今年開始到現在

-36.10%

1年

-39.55%

關鍵數據
18.510今開
18.650最高
1.22M成交量
虧損本益比TTM
7.16本益比動
--股利TTM
1.80%換手率
18.180昨收
17.830最低
16.50M成交額
虧損本益比靜
0.67市淨率
0.00%股息率 TTM
-20.03%ROA
35.57552週最高
0.71量比
-2.05B淨利潤
68.10M總股本
-17.8511每股盈餘TTM
0.77Beta
-49.95%ROE
9.92052週最低
4.51%振幅
35.01%毛利率
1.24B總市值
4.38回報/風險
4.30%風險率

TradingKey QuidelOrtho Corp股票評分

單位: USD 更新時間: 2026-07-02

操作建議

QuidelOrtho Corp當前公司基本面數據相對穩定,增長潛力很大。當前估值合理,在醫療設備與耗材行業排名88/204位。機構持股佔比非常高,近一月多位分析師給出公司評級為持有。最高目標價為21.17。中期看,股價處於上升通道。近一個月,市場表現很強,技術面和基本面綜合得分較高,很強的走勢得到基本面和技術面的印證。目前股價在壓力位和支撐位之間,可以做區間波段操作。

QuidelOrtho Corp評分

相關信息

行業排名
88 / 204
全市場排名
202 / 4565
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

公司輿情

過去24小時
熱度

過冷
過熱
看好

QuidelOrtho Corp亮點

亮點風險
QuidelOrtho Corporation provides in vitro diagnostics, developing and manufacturing intelligent solutions. The Company specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. It provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics and Ortho Optix.
利潤高增長
公司淨利潤處於行業前列,最新年度總收入2.73B美元
估值高估
公司最新PE估值-1.02,處於3年歷史高位
機構減倉
最新機構持股88.33M股,環比減少13.83%
保羅都鐸瓊斯持倉
明星投資者保羅都鐸瓊斯持倉,最新持倉312.25K股
活躍度降低
近期活躍度降低,過去20天平均換手率0.45

分析師目標

基於 4 分析師
持有
評級
21.167
目標均價
+16.43%
漲幅空間

QuidelOrtho Corp新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

QuidelOrtho Corp簡介

QuidelOrtho Corporation provides in vitro diagnostics, developing and manufacturing intelligent solutions. The Company specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. It provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics and Ortho Optix.
公司代碼QDEL
公司QuidelOrtho Corp
CEOBlaser (Brian J)
網址https://www.quidelortho.com/

常見問題

QuidelOrtho Corp(QDEL)的當前股價是多少?

QuidelOrtho Corp(QDEL)的當前股價是 18.25。

QuidelOrtho Corp 的股票代碼是什麼?

QuidelOrtho Corp的股票代碼是QDEL。

QuidelOrtho Corp股票的52週最高點是多少?

QuidelOrtho Corp股票的52週最高點是35.58。

QuidelOrtho Corp股票的52週最低點是多少?

QuidelOrtho Corp股票的52週最低點是9.92。

QuidelOrtho Corp的市值是多少?

QuidelOrtho Corp的市值是1.24B。

現在QuidelOrtho Corp(QDEL)的股票是買入、持有還是賣出?

根據分析師評級,QuidelOrtho Corp(QDEL)的總體評級為signal_hold,目標價格為21.17。

QuidelOrtho Corp(QDEL)股票的每股收益(EPS TTM)是多少

QuidelOrtho Corp(QDEL)股票的每股收益(EPS TTM)是-16.69。